专利检索 ap:("Peter Aranyi" OR "Laszlo Balazs" OR "Sandor Batori" OR "Judit Bence" OR "Kinga Boer" OR "Felix Hadju" OR "Zoltan Kapui" OR "Endre Mikus" OR "Tibor Szabo" OR "Lajos T. Nagy" OR "Geza Timari" OR "Katalin Urban-Szabo" OR "Erzsebet Walcz") AND inv:"Tibor Szabo" 第 1 页

1.

发明申请
Triazolo-quinolin derivatives useful as adenosine receptor ligands 失效
标题翻译：用作腺苷受体配体的三唑并喹啉衍生物

公开(公告)号：US20050124648A1

公开(公告)日：2005-06-09

申请号：US10499250

申请日：2002-12-17

申请人： Peter Aranyi , Laszlo Balazs , Sandor Batori , Judit Bence , Kinga Boer , Felix Hadju , Zoltan Kapui , Endre Mikus , Tibor Szabo , Lajos T. Nagy , Geza Timari , Katalin Urban-Szabo , Erzsebet Walcz

发明人： Peter Aranyi , Laszlo Balazs , Sandor Batori , Judit Bence , Kinga Boer , Felix Hadju , Zoltan Kapui , Endre Mikus , Tibor Szabo , Lajos T. Nagy , Geza Timari , Katalin Urban-Szabo , Erzsebet Walcz

IPC分类号： A61K31/437 , A61K31/444 , A61P9/00 , A61P11/00 , A61P13/12 , A61P25/00 , A61P29/00 , A61P35/00 , A61P37/02 , A61P37/06 , C07B61/00 , C07D215/54 , C07D215/56 , C07D471/04 , A61K31/4745

CPC分类号： C07D471/04 , C07D215/54 , C07D215/56

摘要： The present invention relates to adenosine A-3? receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and theirs salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and to the preparation thereof.

摘要翻译： 本发明涉及腺苷A- 3？通式（I）的受体配体，在这些优选的拮抗剂中，以及它们的盐，溶剂合物和异构体，以及含有它们的药物组合物，通式（I）的化合物以及它们的盐，溶剂合物和异构体，制备通式（I）化合物及其盐，溶剂合物和异构体，以及通式（II）的新中间体及其制备方法。

2.

发明授权
Triazolo-quinolin derivatives useful as adenosine receptor ligands 失效
标题翻译：用作腺苷受体配体的三唑并喹啉衍生物

公开(公告)号：US07713992B2

公开(公告)日：2010-05-11

申请号：US12039272

申请日：2008-02-28

申请人： Peter Aranyi , Laszlo Balazs , Sandor Batori , Judit Bence , Kinga Boer , Felix Hajdu , Zoltan Kapui , Endre Mikus , Tibor Szabo , Lajos T. Nagy , Geza Timari , Katalin Urban-Szabo , Erzsebet Walcz

发明人： Peter Aranyi , Laszlo Balazs , Sandor Batori , Judit Bence , Kinga Boer , Felix Hajdu , Zoltan Kapui , Endre Mikus , Tibor Szabo , Lajos T. Nagy , Geza Timari , Katalin Urban-Szabo , Erzsebet Walcz

IPC分类号： A61K31/4355 , A61K31/4196

CPC分类号： C07D471/04 , C07D215/54 , C07D215/56

摘要： The present invention relates to adenosine A3 receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and their salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and to the preparation thereof.

摘要翻译： 本发明涉及通式（I）的腺苷A3受体配体，其中优选为拮抗剂，以及它们的盐，溶剂化物和异构体，以及含有它们的药物组合物，以及通式 I）以及它们的盐，溶剂合物和异构体，通式（I）的化合物及其盐，溶剂合物和异构体的制备，以及通式（II）的新中间体和制备其中。

3.

发明授权
Triazolo-quinolin derivatives useful as adenosine receptor ligands 失效
标题翻译：用作腺苷受体配体的三唑并喹啉衍生物

公开(公告)号：US07365089B2

公开(公告)日：2008-04-29

申请号：US10499250

申请日：2002-12-17

申请人： Peter Aranyi , Laszlo Balazs , Sandor Batori , Judit Bence , Kinga Boer , Felix Hajdu , Zoltan Kapui , Endre Mikus , Tibor Szabo , Lajos T. Nagy , Geza Timari , Katalin Urban-Szabo , Erzsebet Walcz

发明人： Peter Aranyi , Laszlo Balazs , Sandor Batori , Judit Bence , Kinga Boer , Felix Hajdu , Zoltan Kapui , Endre Mikus , Tibor Szabo , Lajos T. Nagy , Geza Timari , Katalin Urban-Szabo , Erzsebet Walcz

IPC分类号： A61K31/4196 , A61K31/4406 , C07D251/72

CPC分类号： C07D471/04 , C07D215/54 , C07D215/56

摘要： The present invention relates to adenosine A3? receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and theirs salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and to the preparation thereof.

摘要翻译： 本发明涉及腺苷A 3？通式（I）的受体配体，在这些优选的拮抗剂中，以及它们的盐，溶剂合物和异构体，以及含有它们的药物组合物，通式（I）的化合物以及它们的盐，溶剂合物和异构体，制备通式（I）化合物及其盐，溶剂合物和异构体，以及通式（II）的新中间体及其制备方法。

4.

发明申请
Triazolo-Quinolin Derivatives Useful as Adenosine Receptor Ligands 失效
标题翻译：可用作腺苷受体配体的三唑并喹啉衍生物

公开(公告)号：US20080146604A1

公开(公告)日：2008-06-19

申请号：US12039272

申请日：2008-02-28

申请人： Peter Aranyi , Laszlo Balazs , Sandor Batori , Judit Bence , Kinga Boer , Felix Hajdu , Zoltan Kapui , Endre Mikus , Tibor Szabo , Lajos T. Nagy , Geza Timari , Katalin Urban-Szabo , Erzsebet Walcz

发明人： Peter Aranyi , Laszlo Balazs , Sandor Batori , Judit Bence , Kinga Boer , Felix Hajdu , Zoltan Kapui , Endre Mikus , Tibor Szabo , Lajos T. Nagy , Geza Timari , Katalin Urban-Szabo , Erzsebet Walcz

IPC分类号： A61K31/437 , A61P11/06 , A61P11/00 , A61P13/12 , A61P37/00 , A61P35/00

CPC分类号： C07D471/04 , C07D215/54 , C07D215/56

摘要： The present invention relates to adenosine A3 receptor ligands of the general formula (I), within those preferably antagonists, as well as their salts, solvates and isomers, and the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I), as well as their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and their salts, solvates and isomers, furthermore to the new intermediates of the general formulae (II) and to the preparation thereof.

摘要翻译： 本发明涉及通式（I）的腺苷A 3 N 3受体配体，其中优选的是拮抗剂，以及它们的盐，溶剂化物和异构体，以及含有它们的药物组合物的通式（I）化合物及其盐，溶剂合物和异构体制备通式（I）化合物及其盐，溶剂合物和异构体，此外还涉及一般的新的中间体式（II）及其制备方法。

5.

发明授权
Compounds 有权
标题翻译：化合物

公开(公告)号：US08338411B2

公开(公告)日：2012-12-25

申请号：US12631139

申请日：2009-12-04

申请人： Edit Susan , Kinga Boer , Zoltan Kapui , Geza Timari , Sandor Batori , Zoltan Szlavik , Endre Mikus , Judit Vargane Szeredi , Michel Finet , Katalin Urban Szabo , Tibor Szabo

发明人： Edit Susan , Kinga Boer , Zoltan Kapui , Geza Timari , Sandor Batori , Zoltan Szlavik , Endre Mikus , Judit Vargane Szeredi , Michel Finet , Katalin Urban Szabo , Tibor Szabo

IPC分类号： A61K31/535 , C07D215/38

CPC分类号： C07D471/04

摘要： The present invention relates to the adenosine A3 receptor ligands of the general formula (I), within them favourably to the antagonists, to their salts, solvates, N-oxides and isomers, to the pharmaceutical compositions containing the compounds of the general formula (I), their salts, solvates, N-oxides and isomers, to the use of the compounds of the general formula (I), their salts, solvates, N-oxides and isomers, to the preparation of the compounds of the general formula (I), their salts, solvates, N-oxides and isomers, as well as to the new intermediates of the general formula (II), (VI), (XI), (XII) and (XV), and to the preparation thereof.

摘要翻译： 本发明涉及含有通式（I）的化合物的药物组合物，其通式（I）的腺苷A 3受体配体，其有利于拮抗剂，其盐，溶剂合物，N-氧化物和异构体，），它们的盐，溶剂合物，N-氧化物和异构体，通式（I）的化合物，其盐，溶剂合物，N-氧化物和异构体用于制备通式（I ），它们的盐，溶剂合物，N-氧化物和异构体，以及通式（II），（VI），（XI），（XII）和（XV）的新中间体及其制备。

6.

发明授权
Amino-alkyl amide derivatives as CCR3 receptor ligands 失效
标题翻译：氨基 - 烷基酰胺衍生物作为CCR3受体配体

公开(公告)号：US08044078B2

公开(公告)日：2011-10-25

申请号：US12050964

申请日：2008-03-19

申请人： Agnes Pappne Behr , Zoltan Kapui , Peter Aranyi , Sandor Batori , Veronika Bartane Bodor , Lajos T. Nagy , Mihalyne Santa, legal representative , Marton Varga , Endre Mikus , Katalin Urban-Szabo , Judit Vargane Szeredi , Tibor Szabo , Edit Susan , Marianna Kovacs

发明人： Agnes Pappne Behr , Zoltan Kapui , Peter Aranyi , Sandor Batori , Veronika Bartane Bodor , Lajos T. Nagy , Marton Varga , Endre Mikus , Katalin Urban-Szabo , Judit Vargane Szeredi , Tibor Szabo , Edit Susan , Marianna Kovacs

IPC分类号： A61K31/428 , A61K31/165 , A61K31/4184 , A61P31/18 , C07D277/68 , C07D235/26 , C07C233/00

CPC分类号： C07C233/36 , C07D263/58 , C07D277/68 , C07D277/82

摘要： The invention relates to a compound of the general formula (I), as defined herein which is useful for the treatment of a pathology in a patient wherein a CCR3 receptor plays a role in the development of the pathology, and pharmaceutical preparations containing such compound. The invention is also directed to a process for preparing the compound of the general formula (I), and intermediate useful in the preparation.

摘要翻译： 本发明涉及如本文所定义的通式（I）化合物，其可用于治疗CCR3受体在病理发展中起作用的患者的病理学，以及含有该化合物的药物制剂。本发明还涉及制备通式（I）化合物和制备中使用的中间体的方法。